Hypoglycemia is associated with increased worry and lower quality of life among patients with type 2 diabetes treated with oral antihyperglycemic agents in the Asia-Pacific region

Diabetes Research and Clinical Practice

Volumn 96, Issue 2, 2012, Pages 141-148

  Sheu, Wayne H H ^a   Ji, Li Nong ^b   Nitiyanant, Wannee ^c   Baik, Sei Hyun ^d   Yin, Donald ^e   Mavros, Panagiotis ^e   Chan, Siew Pheng ^f  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c MAHIDOL UNIVERSITY   (Thailand)

^d Korea University College of Medicine   (South Korea)

^e MERCK RESEARCH LABORATORIES   (United States)

^f UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Diabetes; Hypoglycemia; Quality of life; Worry

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; HEMOGLOBIN A1C; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; ARTICLE; ASIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EMOTION; EUROQOL 5 DIMENSIONS QUESTIONNAIRE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT DURATION; VISUAL ANALOG SCALE; WORRY;

ADMINISTRATION, ORAL; AGED; ANXIETY; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; KOREA; MALAYSIA; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; TAIWAN; THAILAND;

EID: 84860518968     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.12.027     Document Type: Article

References (34)

1. Chan J.C.N., Malik V., Jia W., Kadowaki T., Yajnik C.S., Yoon K., et al. Diabetes in Asia: epidemiology risk factors, and pathophysiology. J Am Med Assoc 2009, 301(20):2129-2140.
2. Diabetes Atlas, third edition. [date accessed 7.10.11]. http://www.eatlas.idf.org/.
3. Yang W.Y., Lu J.M., Weng J.P., Jia W.P., Ji L.N., Xiao J.Z., et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362(12):1090-1101.
4. Chang C.H., Shau W.Y., Jiang Y.D., Li H.Y., Chang T.J., Sheu W.H., et al. Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study. Diabet Med 2010, 27(6):636-643.
5. Amiel S.A., Dixon T., Mann R., Jameson K. Hypoglycaemia in type 2 diabetes. Diabet Med 2008, 25(3):245-254.
6. Chan S.P., Ji L.N., Nitiyanant W., Baik S.H., Sheu W.H. Hypoglycemic symptoms in patients with type 2 diabetes in Asia-Pacific-Real-Life Effectiveness and Care Patterns of Diabetes Management: The RECAP-DM study. Diabetes Res Clin Pract 2010, 89(2):e30-e32.
7. Murata G.H., Duckworth W.C., Hoffman R.M., Wendel C.S., Mohler M.J., Shah J.H. Hypoglycemia in type 2 diabetes: a critical review. Biomed Pharmacother 2004, 58(10):551-559.
8. Alvarez G.F., Tofe Povedano S., Krishnarajah G., Lyu R., Mavros P., Yin D. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes management (RECAP-DM) study. Diabetes Obes Metab 2008, 10(Suppl. 1):25-32.
9. American Diabetes Association Standards of medical care in diabetes. Diabetes Care 2005, 28(Suppl. 1):S4-S36.
10. The EuroQol Group EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990, 16(3):199-208.
11. Brooks R. EuroQol: the current state of play. Health Policy 1996, 37(1):53-72.
12. Dolan P., Gudex C., Kind P., Williams A. The time trade-off method: results from a general population study. Health Econ 1996, 5(2):141-154.
13. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997, 35(11):1095-1108.
14. Cox D.J., Irvine A., Gonderfrederick L., Nowacek G., Butterfield J. Fear of hypoglycemia - quantification, validation, and utilization. Diabetes Care 1987, 10(5):617-621.
15. Irvine A.A., Cox D., Gonder-Frederick L. Fear of hypoglycemia: relationship to physical and psychological symptoms in patients with insulin-dependent diabetes mellitus. Health Psychol 1992, 11(2):135-138.
16. Polonsky W.H., Davis C.L., Jacobson A.M., Anderson B.J. Correlates of hypoglycemic fear in type I and type II diabetes mellitus. Health Psychol 1992, 11(3):199-202.
17. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007, 50(6):1140-1147. The UK Hypoglycaemia Study Group.
18. Lundkvist J., Berne C., Bolinder B., Jonsson L. The economic and quality of life impact of hypoglycemia. Eur J Health Econ 2005, 6(3):197-202.
19. Tabaei B.P., Shill-Novak J., Brandle M., Burke R., Kaplan R.M., Herman W.H. Glycemia and the quality of well-being in patients with diabetes. Qual Life Res 2004, 13(6):1153-1161.
20. Davis R.E., Morrissey M., Peters J.R., Wittrup-Jensen K., Kennedy-Martin T., Currie C.J. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005, 21(9):1477-1483.
21. Vexiau P., Mavros P., Krishnarajah G., Lyu R., Yin D. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes Obes Metab 2008, 10:16-24.
22. Nitiyanant W., Tandhanand S., Mahtab H., Zhu X.X., Pan C.Y., Raheja B.S., et al. The Diabcare-Asia 1998 study - outcomes on control and complications in type 1 and type 2 diabetic patients. Curr Med Res Opin 2002, 18(5):317-327.
23. Mohamed M. An audit on diabetes management in Asian patients treated by specialists: the Diabcare-Asia 1998 and 2003 studies. Curr Med Res Opin 2008, 24(2):507-514.
24. Jacobson A.M., de Groot M., Samson J.A. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 1994, 17(4):267-274.
25. Shiu A.T., Thompson D.R., Wong R.Y. Quality of life and its predictors among Hong Kong Chinese patients with diabetes. J Clin Nurs 2008, 17(5A):125-132.
26. Shiu A.T., Wong R.Y. Fear of hypoglycaemia among insulin-treated Hong Kong Chinese patients: implications for diabetes patient education. Patient Educ Couns 2000, 41(3):251-261.
27. Wild D., von Maltzahn R., Brohan E., Christensen T., Clauson P., Gonder-Frederick L. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ Couns 2007, 68(1):10-15.
28. Donnelly L.A., Morris A.D., Frier B.M., Ellis J.D., Donnan P.T., Durrant R., et al. Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med 2005, 22:749-755.
29. Miller C.D., Phillips L.S., Ziemer D.C., Gallina D.L., Cook C.B., El-Kebbi I.M. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 2001, 161:1653-1659.
30. Coteur G., Feagan B., Keininger D.L., Kosinski M. Evaluation of the meaningfulness of health-related quality of life improvements as assessed by the SF-36 and the EQ-5D VAS in patients with active Crohn's disease. Aliment Pharmacol Ther 2009, 29(9):1032-1041.
31. Shikiar R., Willian M.K., Okun M.M., Thompson C.S., Revicki D.A. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health Qual Life Outcomes 2006, 4:71.
32. Walters S.J., Brazier J.E. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005, 14(6):1523-1532.
33. Marra C.A., Woolcott J.C., Kopec J.A., Shojania K., Offer R., Brazier J.E., et al. A comparison of generic, indirect utility measures (the HUI2 HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 2005, 60(7):1571-1582.
34. Shiu A.T., Wong R.Y. Reliability and validity of the Chinese version of the Worry Scale. Public Health Nurs 2004, 21(3):257-265.